Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

17.9K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

15.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing gene perturbations in single cells via network divergence analysis.

Nature communications·2026
Same author

Cell neighborhood topology directs rare cell population identification.

Nature communications·2026
Same author

Construction of the cancer cell continuum reveals hybrid EMT state driving lung adenocarcinoma aggression.

Cancer gene therapy·2025
Same author

Single cell transcriptomics correlate avian coronavirus prime vaccination efficacy with antigen-presenting cell preference.

NPJ vaccines·2025
Same author

Hydrophobicity causes anomalous migration of cystine/glutamate antiporter SLC7A11 in SDS-PAGE with low acrylamide concentration.

FEBS open bio·2025
Same author

HEARTSVG: a fast and accurate method for identifying spatially variable genes in large-scale spatial transcriptomics.

Nature communications·2024
Same journal

Transcriptomic analysis reveals FcγR-mediated phagocytosis as a key pathway for the anti-inflammatory action of <i>Polygonatum sibiricum</i> polysaccharides in loach.

Frontiers in genetics·2026
Same journal

A novel <i>ABO</i> splice site variant underlying the A<sub>3</sub> phenotype: immunogenetic basis and functional dissection.

Frontiers in genetics·2026
Same journal

Case Report: Identification of two novel <i>ALMS1</i> variants in a patient with a ciliopathy resembling Alström syndrome.

Frontiers in genetics·2026
Same journal

Integrative analysis identifies Hspa5 as a key regulator of the ERS/UPR-immune axis in spinal cord injury.

Frontiers in genetics·2026
Same journal

Evaluation of genomic selection to improve survival of eastern oysters infected with <i>Perkinsus marinus</i>.

Frontiers in genetics·2026
Same journal

A rescue assay for genetic diagnosis of oculocutaneous albinism using melanocytic MNT1 knock-out cells.

Frontiers in genetics·2026
See all related articles

Related Experiment Video

Updated: Aug 27, 2025

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.2K

STS-BN: An efficient Bayesian network method for detecting causal SNPs.

Yanran Ma1, Botao Fa2, Xin Yuan1

  • 1Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.

Frontiers in Genetics
|October 3, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a new Bayesian network method to accurately identify causal single nucleotide polymorphisms (SNPs) for complex diseases from large genome-wide association studies, improving upon existing low-accuracy methods.

Keywords:
Bayesian networkGWAScomplex diseaseepistasistwo-stage method

More Related Videos

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.3K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.1K

Related Experiment Videos

Last Updated: Aug 27, 2025

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.2K
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.3K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.1K

Area of Science:

  • Genetics and Genomics
  • Computational Biology
  • Biostatistics

Background:

  • Identifying causal single nucleotide polymorphisms (SNPs) is crucial for understanding complex disease pathogenesis, prevention, diagnosis, and treatment.
  • Current methods for large-scale genome-wide association studies (GWAS) often lack sufficient accuracy in causal SNP detection.
  • There is a significant need for more powerful and accurate computational methods for identifying disease-associated SNPs.

Purpose of the Study:

  • To develop and evaluate a novel, accurate method for identifying causal SNPs associated with complex diseases using large-scale GWAS data.
  • To improve upon the accuracy and stability of existing methods for SNP detection in case-control study designs.

Main Methods:

  • A score-based, two-stage Bayesian network approach was developed to learn the structure of a disease-centered local Bayesian network.
  • The method integrates principles from constraint-based and score-and-search algorithms for network structure learning.
  • Performance was assessed through simulation experiments and application to real-world genome-wide association data.

Main Results:

  • The proposed Bayesian network method demonstrated improved accuracy and stability compared to several common alternative methods.
  • The algorithm achieved lower false-positive rates while successfully detecting all correct causal loci.
  • Application to real-world GWAS data confirmed the algorithm's robust performance in handling large datasets.

Conclusions:

  • The developed score-based two-stage Bayesian network method is effective for identifying SNPs related to complex diseases.
  • This novel approach offers superior accuracy compared to existing methods applicable to large-scale genome-wide association studies.